Skip to main content

Table 1 Characteristics of patients

From: MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer

Variable Number %
Age (years) 42.58 ± 12.15a  
Diagnostic category   
 Normal 541 46.4
 Low-grade CIN 99 8.5
 High-grade CIN 327 28.0
 Cancer 200 17.1
FIGO stage   
 I 138 69.0
 II 53 26.5
 IV 9 4.5
Tumor grade b   
 Well/Moderate 117 65.7
 Poor 61 34.3
Cell type   
 SCC 164 82.0
 AC/ASC 30 15.0
 Others 6 3.0
Tumor size   
  ≤ 4 cm 145 72.5
  > 4 cm 55 27.5
Lymphovascular invasion c   
 Negative 95 64.6
 Positive 52 35.4
Lymph node metastasis d   
 Negative 141 77.5
 Positive 41 22.5
Chemoradiation response e   
 Good 38 77.6
 Bad 11 22.4
SCC antigen f   
 Negative 100 66.7
 Positive 50 33.3
HPV test in CIN g   
 Negative 39 11.5
 Positive 300 88.5
  1. CIN, cervical intraepithelial neoplasia; FIGO, International Federation of Gynecology and Obstetrics; SCC, squamous cell carcinoma; AC, adenocarcinoma; ASC, adenosquamous carcinoma. amean ± standard deviation, bcalculated only for the 178 cases with available information on tumor grade, ccalculated only for the 147 cases with available information on examined lymphovascular invasion, dcalculated only for the 182 cases with available information on examined lymph nodes, ecalculated only for the 49 cases with available information on chemoradiation response, fcalculated only for the 114 cases with available information on SCC antigen level, gcalculated only for the 339 CIN cases with available information on HPV infection.